ARTIS Ventures

ARTIS Ventures is a San Francisco-based venture capital firm established in 2001 that focuses on early-to-late-stage investments in various sectors, including consumer goods, healthcare, artificial intelligence, machine learning, quantum computing, smart data, engineering, diagnostics, targeted therapeutics, medical devices, and wellness. The firm is dedicated to supporting its portfolio companies throughout their entire lifecycle, from initial investment to public offering and beyond. As a Registered Investment Adviser, ARTIS Ventures aims to identify and nurture innovative startups within its targeted industries, contributing to their growth and success in the competitive market.

Ameena El-Bibany

Partner

Henry Klingenstein

Partner

Niraj Mehta

Associate

Stuart Peterson

Managing General Partner and Founder

Austin Walne

Partner

116 past transactions

Delfina

Series A in 2025
Delfina is a company that specializes in developing a personalized prenatal care system aimed at ensuring the safety of mothers and infants during pregnancy. By leveraging data and machine learning, Delfina's platform creates individualized pregnancy care plans that assess patient risk through various metrics. This approach not only enhances interventional workflows but also improves provider efficiency, facilitating early intervention in prenatal care. Delfina's commitment to data-driven insights is paving the way for clinical innovation, ultimately striving to deliver equitable and cost-effective healthcare solutions for expectant families.

Conceivable Life Sciences

Series A in 2025
Conceivable Life Sciences is focused on revolutionizing in vitro fertilization (IVF) by developing the first fully automated IVF laboratory. The company employs advanced technologies, including single-cell robotics, to streamline the IVF process, making it more efficient and accessible to individuals and couples aspiring to become parents. By automating key aspects of IVF, Conceivable Life Sciences aims to democratize access to these reproductive technologies, ultimately helping more people fulfill their dreams of parenthood.

Second Front

Series C in 2024
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

Luminate Medical

Venture Round in 2024
Luminate Medical is focused on developing a medical device aimed at preventing hair loss during chemotherapy. Recognizing the significance of hair for personal identity and self-esteem, the company has created a portable and comfortable wearable system. This innovative device allows patients to manage and mitigate the side effects associated with cancer treatment, thereby helping them maintain their confidence and dignity during a challenging time. By leveraging advances in medical technology, Luminate Medical is dedicated to enhancing the quality of life for individuals undergoing chemotherapy.

Rad AI

Series B in 2024
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.

OverT Bio

Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the barriers posed by tumors. By enhancing the effectiveness and durability of immunotherapies, OverT Bio aims to advance the healthcare field's ability to identify and ultimately cure cancer.

Power Life Science

Series A in 2023
Power Life Science believes that every patient deserves the chance to participate in a life-changing clinical trial. Is backed by some of the best healthcare investors and operators with a range of experience across clinical research and biopharmaceuticals. We are a small team - each of us with our own personal story and motivation to make a difference in the lives of patients.

Unnatural Products

Series A in 2023
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, specializing in drug discovery through the innovative use of macrocyclic peptides. Founded in 2016, the company employs artificial intelligence and computational biology techniques to engineer these peptides, allowing them to target previously undruggable protein interactions. By leveraging machine learning for parallel chemical synthesis, Unnatural Products aims to optimize macrocyclic compounds efficiently, thereby accelerating the drug discovery process. This technology addresses a significant gap in therapeutic strategies, offering potential treatments for a wide range of diseases linked to difficult-to-target drug candidates.

Ozlo Sleep

Series A in 2023
Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.

Affect Therapeutics

Series A in 2023
Affect Therapeutics operates a digital treatment platform designed to address drug and alcohol addiction through a mobile application. The company offers an integrated program for various substance use disorders, utilizing contingency management and reward systems to engage users and promote retention. By providing financial incentives, the platform encourages patients to adopt healthier behaviors and establish new habits, ultimately aiming to improve outcomes for individuals seeking to overcome addiction.

Range Biotechnologies

Seed Round in 2023
Range Biotechnologies develops innovative tools focused on personalized health through translational proteomics. The company's technology allows for the precise measurement of multiple proteins across various samples simultaneously. This capability provides healthcare professionals with valuable insights into the fundamental mechanisms of diseases and their progression over time, ultimately advancing human health.

Siren Biotechnology

Seed Round in 2023
Siren Biotechnology is a biotech company focused on innovating cancer treatment through a unique gene therapy platform. By integrating adeno-associated virus (AAV) gene therapy with cytokine immunotherapy, Siren Biotechnology has developed a novel therapeutic approach. This combination aims to address significant challenges in cancer treatment, including delivery methods, efficacy, and toxicity, ultimately enhancing the elimination of tumor cells and stimulating anti-tumor immunity. Through this redesigned modality, the company seeks to transform the landscape of cancer therapies, offering new hope for patients facing this disease.

Outpace Bio

Series A in 2023
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Affect Therapeutics

Series A in 2023
Affect Therapeutics operates a digital treatment platform designed to address drug and alcohol addiction through a mobile application. The company offers an integrated program for various substance use disorders, utilizing contingency management and reward systems to engage users and promote retention. By providing financial incentives, the platform encourages patients to adopt healthier behaviors and establish new habits, ultimately aiming to improve outcomes for individuals seeking to overcome addiction.

Second Front

Series A in 2022
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

CURE: One app, all things health

Series A in 2022
CURE Group GmbH is a healthcare on-demand company with the vision to be the easiest access to healthcare services without leaving your home. Today, CURE works with a local pharmacy network and delivers medicine quickly and sustainably. CURE was founded in December 2021 by Ali El-Ali and Manuel Aberle in Berlin. CURE investors include Breega, Craft Ventures, Abstract Ventures, PiLabs, and J12 Ventures, with participation from J Ventures.

Network Bio

Pre Seed Round in 2022
Network Bio operates a clinical and molecular data library focused on facilitating precision medicine for common human diseases. Its platform serves as a centralized repository for clinical and molecular data, allowing researchers to analyze patterns and correlations. This analysis can lead to the development of new treatments and diagnostic tools, thereby advancing medical research and improving patient outcomes.

Power Life Science

Seed Round in 2022
Power Life Science believes that every patient deserves the chance to participate in a life-changing clinical trial. Is backed by some of the best healthcare investors and operators with a range of experience across clinical research and biopharmaceuticals. We are a small team - each of us with our own personal story and motivation to make a difference in the lives of patients.

Science

Seed Round in 2022
Science is a startup company that develops technologies for a range of serious unmet medical needs.

Replay

Seed Round in 2022
Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA sequences. By innovating in the field of genetic engineering, Replay seeks to redefine the possibilities of genome manipulation and its applications in various medical and therapeutic contexts. Their work aims to facilitate breakthroughs in how genes can be utilized to treat diseases and enhance biological functions, positioning them at the forefront of the evolving landscape of genetic technology.

Cartography Biosciences

Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.

Locus Biosciences

Series B in 2022
Locus Biosciences is a biotechnology company focused on developing a CRISPR-engineered precision antibacterial platform aimed at transforming the treatment of bacterial diseases. The company integrates the antibacterial capabilities of CRISPR-Cas3 technology with the effective and safe delivery of bacteriophages, which are viruses that specifically target bacteria. This innovative approach allows for rapid initiation of treatment by physicians, leading to improved medical outcomes for patients. Through its advanced platform, Locus Biosciences seeks to address the challenges posed by pathogenic bacteria in a precise and targeted manner.

Tessera Therapeutics

Series C in 2022
Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the permanent modification of the human genome. This innovative approach enables scientists and clinicians to introduce therapeutic messages into the genome, offering a potential cure for diseases at their source. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics aims to address significant limitations in these areas, enhancing their applicability and effectiveness. Founded by Flagship Pioneering, the company is positioned to transform genetic medicine and improve patient care through its groundbreaking technology.

ONI

Series B in 2021
ONI is a leader in super-resolution microscopy, offering innovative tools that enhance biological research. The company has developed the Nanoimager, the first benchtop super-resolution microscope, which provides unprecedented usability and precision for researchers. This device enables access to various super-resolution techniques, including dSTORM, PALM, smFRET, and single-particle tracking, facilitating a deeper understanding of cellular structures and functions. ONI's products are increasingly adopted by academic researchers and pharmaceutical companies, with installations in prominent laboratories such as those at the Universities of Oxford, Cambridge, and Harvard. The company's mission is to democratize scientific discovery by making advanced imaging technology more accessible and affordable, thereby empowering researchers to visualize and share the intricate details of life. Recognized for its innovative contributions, ONI has received accolades such as being named a Disruptor to Watch and winning Best Business Start-up at the IOP Awards. Through its commitment to advancing scientific research, ONI aims to accelerate discoveries that can lead to improved health outcomes.

Cerebral

Series C in 2021
Cerebral Inc. is a mental health telemedicine company that provides an online membership platform for telehealth visits and care counseling services. Founded in 2019 and headquartered in Walnut, California, Cerebral offers comprehensive support for individuals experiencing anxiety, depression, and insomnia. The platform facilitates medication management, counseling, and therapy, ensuring access to regular visits and communication with care counselors. It employs clinically proven symptom-based ratings and tracking methods to enhance patient care. By prioritizing accessibility and affordability, Cerebral aims to democratize high-quality mental health care, allowing patients to receive timely and effective treatment while following evidence-based guidelines throughout their wellness journey.

Meomind

Pre Seed Round in 2021
Meomind is a developer of a mental health application aimed at making mental health care accessible to all. Its platform features a comprehensive library of pre-recorded therapy sessions that address various mental health needs, allowing users to engage in personalized therapy programs. This approach enhances psychological well-being while removing the barriers often associated with traditional in-person therapy. Additionally, Meomind provides customer support through email and phone contact, ensuring users have access to assistance when needed.

Rad AI

Series A in 2021
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.

MycoMedica Life Sciences

Series A in 2021
MycoMedica Life Sciences, founded by esteemed mycologist Paul Stamets, is a life sciences company dedicated to developing therapeutic drugs derived from fungi. The company focuses on harnessing the healing potential of the fungal genome to address psychiatric and neurological disorders. One of its key innovations, the Stamets Stack, combines unique ingredients that are not found together in nature to enhance the effectiveness of psilocybin for preventing and treating these conditions. MycoMedica aims to advance fungi-based drug development, offering new avenues for medical professionals to improve health outcomes and promote well-being.

Glyphic Biotechnologies

Seed Round in 2021
Glyphic Biotechnologies is a biotechnology company focused on developing an advanced protein sequencing platform that aims to enhance understanding of biological functions and diseases. Unlike DNA sequencing, which offers limited insights, this next-generation platform provides deeper knowledge through single-molecule, massively parallel sequencing. By improving binding affinity and consistency, Glyphic's technology supports the creation of personalized and precision cancer vaccines tailored to individual patients. The company's innovative approach enables scientists and researchers to develop novel therapeutics and diagnostics, ultimately advancing the comprehension of human biology and disease mechanisms.

Cerebral

Series B in 2021
Cerebral Inc. is a mental health telemedicine company that provides an online membership platform for telehealth visits and care counseling services. Founded in 2019 and headquartered in Walnut, California, Cerebral offers comprehensive support for individuals experiencing anxiety, depression, and insomnia. The platform facilitates medication management, counseling, and therapy, ensuring access to regular visits and communication with care counselors. It employs clinically proven symptom-based ratings and tracking methods to enhance patient care. By prioritizing accessibility and affordability, Cerebral aims to democratize high-quality mental health care, allowing patients to receive timely and effective treatment while following evidence-based guidelines throughout their wellness journey.

Athena Club

Series A in 2021
Athena Club is a manufacturer of feminine care products that focuses on providing essential items for body, wellness, and period care. The company's product range includes tampons, razor kits, shave foam, body wash, face wipes, multivitamins, and probiotics. Athena Club aims to enhance personal care by utilizing efficient, high-quality ingredients and sustainable packaging, while also incorporating innovative patented technologies. By offering these products through a subscription model, Athena Club enables women to receive affordable personal care items conveniently delivered to their doorsteps.

ViaCyte

Series D in 2021
ViaCyte, Inc. is a regenerative medicine company based in San Diego, California, that specializes in developing cell replacement therapies for diabetes. The company’s primary product candidates, VC-01 and VC-02, aim to treat type 1 diabetes by implanting pancreatic beta-cell precursors derived from stem cells within an encapsulation device. This innovative approach allows the implanted cells to produce insulin in response to blood glucose levels while minimizing the risk of immune rejection, thereby eliminating the need for immunosuppressants. ViaCyte's goal is to provide a long-term solution that can free both type 1 and type 2 diabetes patients from dependence on insulin and reduce associated complications such as hypoglycemia and cardiovascular issues. Founded in 1999, ViaCyte was previously known as Novocell, Inc., and changed its name in 2010. The company also operates an additional facility in Athens, Georgia.

Seed Health

Series A in 2021
Seed Health is a biotechnology company focused on advancing health through innovative applications of microbial sciences. The company develops health supplements that combine probiotics and prebiotics, targeting various aspects of well-being, including digestive health, skin health, heart health, and micronutrient synthesis. By collaborating with academic researchers, Seed Health aims to bring breakthrough discoveries to market, offering consumers live biotherapeutics designed to enhance both human and environmental health.

Transparent Health Marketplace

Series C in 2021
Transparent Health Marketplace, Inc. operates an innovative online marketplace designed for the procurement and delivery of healthcare services within the workers' compensation sector. The company's platform, THM, connects healthcare service providers with payors, including carriers, third-party administrators, and employers, facilitating the efficient care of injured workers. By introducing market-driven pricing, THM allows providers to set their own prices and receive prompt payment for awarded contracts, moving away from traditional network contract models. Founded in 2016 and headquartered in Wayne, Pennsylvania, Transparent Health Marketplace aims to streamline the process of obtaining necessary healthcare services for injured workers through its unique marketplace approach.

Outpace Bio

Series A in 2021
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Excision BioTherapeutics

Venture Round in 2021
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Excision BioTherapeutics

Series A in 2021
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Second Front

Funding Round in 2021
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

Eko Health

Series C in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Climax Foods

Seed Round in 2020
Climax Foods Inc. is a Berkeley, California-based company that specializes in producing plant-based foods using advanced artificial intelligence technology. Incorporated in 2019, the company employs data science, machine learning, and simulation frameworks to innovate and accelerate food development processes. By focusing on experimentation, Climax Foods rapidly creates dairy alternatives that are optimized for taste, texture, nutrition, and cost. This technology enables clients to manufacture plant-based products that can effectively compete with traditional animal-based foods, aiming to transform the global food production system.

Replay

Seed Round in 2020
Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA sequences. By innovating in the field of genetic engineering, Replay seeks to redefine the possibilities of genome manipulation and its applications in various medical and therapeutic contexts. Their work aims to facilitate breakthroughs in how genes can be utilized to treat diseases and enhance biological functions, positioning them at the forefront of the evolving landscape of genetic technology.

Lemonaid Health

Series B in 2020
Lemonaid Health is an online telemedicine platform founded in 2013 and headquartered in San Francisco, California. The company aims to enhance the patient experience and optimize clinical care by utilizing advancements in machine learning and artificial intelligence. By collecting details about medical history, symptoms, current medications, and allergies, Lemonaid Health employs evidence-based guidelines to provide patients with prescriptions. This approach allows users to access quality healthcare services at a price point lower than typical co-pays, making healthcare more affordable and accessible.

Activ Surgical

Venture Round in 2020
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, focused on enhancing surgical efficiency, accuracy, and patient outcomes through advanced technology. Founded in 2014, the company has developed a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. One of its key products is the Smart Tissue Autonomous Robot (STAR), which aims to revolutionize surgical practices by improving intraoperative decision-making and reducing the risk of unintended surgical complications. The platform is scalable and patent-protected, designed to support surgeons with augmented reality and data-driven insights, ultimately making surgeries safer and more effective.

Replay

Seed Round in 2020
Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA sequences. By innovating in the field of genetic engineering, Replay seeks to redefine the possibilities of genome manipulation and its applications in various medical and therapeutic contexts. Their work aims to facilitate breakthroughs in how genes can be utilized to treat diseases and enhance biological functions, positioning them at the forefront of the evolving landscape of genetic technology.

Second Front

Seed Round in 2020
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

Creator Cash

Seed Round in 2020
Creator Cash is a financial services platform designed specifically for social media creators. Founded in 2020 and headquartered in San Francisco, California, the company offers a range of financial products, including savings accounts and debit cards. In addition to its financial services, Creator Cash provides valuable insights into earnings and revenue, helping creators effectively manage their YouTube channels. As a subsidiary of ChannelMeter, Inc., Creator Cash aims to support creators in navigating their financial needs within the digital landscape.

TAE Life Sciences

Series B in 2020
TAE Life Sciences, LLC is a biotechnology company based in Foothill Ranch, California, focused on developing innovative medical technologies centered around Boron Neutron Capture Therapy (BNCT). Founded in 2017, the company aims to improve treatment options for patients suffering from rapidly spreading, invasive, and recurrent cancers that have proven resistant to conventional therapies. TAE Life Sciences stands out as the only entity with a comprehensive portfolio of biological-targeting radiation therapy and neutron beam technology, which positions it to offer next-generation combination cancer therapies. By enabling clinical access to this advanced treatment modality, the company seeks to provide effective solutions for patients with inoperable and difficult-to-treat cancers, ultimately aiming to extend their lives.

Idbydna

Series B in 2020
IDbyDNA, Inc. is a company specializing in metagenomics technologies aimed at identifying infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, it has developed a platform called Explify, which enables laboratories to detect and characterize pathogens using nucleic acid-based techniques. The company offers comprehensive testing services, including respiratory and research services, catering to hospitals, reference labs, clinical research institutions, and the biopharmaceutical sector. By leveraging computational biology and artificial intelligence, IDbyDNA strives to enhance diagnostic accuracy and treatment precision for infectious diseases, addressing the growing global challenge posed by these conditions.

Crediwatch

Series A in 2019
Crediwatch is an information intelligence platform that connects business and financial data to generate analytics-driven insights for decision-making. It allows businesses and lenders to integrate their private datasets, facilitating the analysis of relevant companies. By providing insights that can be shared with potential lenders and partners, Crediwatch supports the growth of small and medium enterprises in India. The platform utilizes advanced computational techniques, including machine learning and natural language processing, to analyze distributed and unstructured data sources. This enables financial institutions, banks, and corporations to make informed decisions quickly while identifying market opportunities and managing capital risks effectively.

Enklu

Seed Round in 2019
Enklu, Inc. specializes in augmented reality (AR) technology, offering an application that transforms museums and galleries into interactive experiences akin to video games. The company provides Enklu Cloud, a platform that enables users to create and modify content in real time, which can be accessed via web or AR devices such as Microsoft HoloLens. Enklu operates as a three-sided marketplace, connecting players, creators, and operators of real-world AR and mixed reality experiences. Founded in 2016 and based in Alameda, California, the company was formerly known as CreatAR Corp. before rebranding in February 2019.

Astra

Series C in 2019
Astra is a rocket launch startup that provides satellite delivery and launch services. It offers online reservations for payload deliveries to both sun-synchronous and low-inclination orbits. Astra also offers dedicated launch services of 50kg-150kg payloads to 500km SSO reference orbit in 2020 and 2021. The company focuses on providing cost-effective and frequent access to space for small satellite payloads. Astra aims to simplify the process of launching payloads into space by developing lightweight and agile rockets that can be found from various locations. Astra has been actively conducting launch campaigns to demonstrate its capabilities and improve its technology. As with any ambitious space venture, Astra has faced its fair share of challenges and setbacks in developing and launching rockets.

Eko Health

Series B in 2019
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Unnatural Products

Seed Round in 2019
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, specializing in drug discovery through the innovative use of macrocyclic peptides. Founded in 2016, the company employs artificial intelligence and computational biology techniques to engineer these peptides, allowing them to target previously undruggable protein interactions. By leveraging machine learning for parallel chemical synthesis, Unnatural Products aims to optimize macrocyclic compounds efficiently, thereby accelerating the drug discovery process. This technology addresses a significant gap in therapeutic strategies, offering potential treatments for a wide range of diseases linked to difficult-to-target drug candidates.

Food Is Good

Pre Seed Round in 2019
Food Is Good, Inc. is focused on enhancing personal well-being through nutrition. The company has developed the Fig App, a dietary and nutrition application that assists users in creating and identifying customized diet profiles. This platform enables individuals to input their dietary needs and efficiently find suitable grocery options that align with their unique requirements. By streamlining the process of managing dietary restrictions, Food Is Good aims to empower users to make informed food choices that promote their health and wellness.

Roshi

Venture Round in 2019
Roshi Solutions, Inc. specializes in developing software-as-a-service (SaaS) inventory management solutions tailored for cannabis businesses. Founded in 2018 and headquartered in San Francisco, California, Roshi's platform enables manufacturers and distributors to efficiently manage inventory supplies, track orders, and oversee transportation services. It is designed to help businesses optimize production planning and streamline billing processes while ensuring compliance with industry regulations. The platform features advanced capabilities such as real-time integration with METRC, robust audit logs, and custom edit checks to maintain high data integrity. By utilizing proprietary algorithms and predictive analytics, Roshi enhances operational efficiency and supports data-driven decision-making, bringing sophisticated supply chain technologies to the cannabis sector.

Aether Bio

Seed Round in 2018
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Quid

Series E in 2018
Quid, Inc. develops a platform that searches, analyzes, and visualizes collective intelligence to address strategic inquiries. Its software specializes in analyzing text-based data, utilizing advanced techniques such as implicit network analysis and graph theory to create interactive visualizations. Through proprietary algorithms that incorporate artificial intelligence and natural language processing, Quid efficiently uncovers insights from extensive datasets, including news articles, blog posts, company profiles, and patents. The platform is designed for non-technical users in enterprise organizations, enabling them to independently access valuable information and generate unique insights. Quid caters to various sectors, including marketing, public relations, consulting, technology, healthcare, and financial services. Founded in 2006 and headquartered in San Francisco, California, with additional offices in New York and London, Quid merged with NetBase Solutions in January 2020, forming a combined entity known as NetBase Quid.

HeatGen

Venture Round in 2018
HeatGen specializes in self-heating technology that transforms ordinary food and beverage packaging into self-heating containers. This innovative technology allows for the heating of prepared food and beverages through a flameless thermal reaction, enabling consumers to enjoy warm meals and drinks conveniently in various settings, including on-the-go, at offices, during outdoor activities, and in emergency situations. By providing a safe and efficient means of heating food within its packaging, HeatGen serves a wide range of applications in the food and food packaging industries. The company, founded in 2007 and based in Austin, Texas, was previously known as Ironbridge Technologies, Inc.

TAE Life Sciences

Series A in 2018
TAE Life Sciences, LLC is a biotechnology company based in Foothill Ranch, California, focused on developing innovative medical technologies centered around Boron Neutron Capture Therapy (BNCT). Founded in 2017, the company aims to improve treatment options for patients suffering from rapidly spreading, invasive, and recurrent cancers that have proven resistant to conventional therapies. TAE Life Sciences stands out as the only entity with a comprehensive portfolio of biological-targeting radiation therapy and neutron beam technology, which positions it to offer next-generation combination cancer therapies. By enabling clinical access to this advanced treatment modality, the company seeks to provide effective solutions for patients with inoperable and difficult-to-treat cancers, ultimately aiming to extend their lives.

Eko Health

Series A in 2018
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Locus Biosciences

Series A in 2017
Locus Biosciences is a biotechnology company focused on developing a CRISPR-engineered precision antibacterial platform aimed at transforming the treatment of bacterial diseases. The company integrates the antibacterial capabilities of CRISPR-Cas3 technology with the effective and safe delivery of bacteriophages, which are viruses that specifically target bacteria. This innovative approach allows for rapid initiation of treatment by physicians, leading to improved medical outcomes for patients. Through its advanced platform, Locus Biosciences seeks to address the challenges posed by pathogenic bacteria in a precise and targeted manner.

Excision BioTherapeutics

Seed Round in 2017
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Zenrez

Series A in 2017
Zenrez Corporation, founded in 2014 and based in San Francisco, California, operates a mobile application that facilitates the booking of gyms and fitness centers. The company provides boutique fitness studios with advanced sales and marketing software focused on revenue management. By employing dynamic pricing and yield management techniques typically used in larger industries, Zenrez helps studios enhance their revenue, increase customer retention, and fill last-minute class spots. The platform connects fitness enthusiasts with curated local boutique studios, allowing users to discover and book high-quality classes without the need for monthly memberships or fees. Additionally, Zenrez's CRM platform identifies key growth factors and actionable fitness-specific performance indicators, empowering studios to optimize their acquisition and retention strategies.

Versa Networks

Series C in 2016
Versa Networks, Inc. is a company specializing in software-defined networking (SDN) solutions with a focus on virtualized network functions and services. Founded in 2012 and headquartered in Santa Clara, California, with an additional office in Bengaluru, India, Versa aims to secure and simplify modern networks for enterprises and service providers. Their offerings include Secure Access Service Edge (SASE), which integrates security and advanced networking capabilities, alongside a full-featured software-defined wide area network (SD-WAN). Versa's platform supports multitenancy and sophisticated analytics, allowing deployment across cloud, on-premises, or hybrid environments. This versatility helps organizations reduce costs associated with wide area networks and branch infrastructure. Thousands of customers globally rely on Versa to manage their networking and security needs.

Idbydna

Series A in 2016
IDbyDNA, Inc. is a company specializing in metagenomics technologies aimed at identifying infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, it has developed a platform called Explify, which enables laboratories to detect and characterize pathogens using nucleic acid-based techniques. The company offers comprehensive testing services, including respiratory and research services, catering to hospitals, reference labs, clinical research institutions, and the biopharmaceutical sector. By leveraging computational biology and artificial intelligence, IDbyDNA strives to enhance diagnostic accuracy and treatment precision for infectious diseases, addressing the growing global challenge posed by these conditions.

Zenrez

Seed Round in 2016
Zenrez Corporation, founded in 2014 and based in San Francisco, California, operates a mobile application that facilitates the booking of gyms and fitness centers. The company provides boutique fitness studios with advanced sales and marketing software focused on revenue management. By employing dynamic pricing and yield management techniques typically used in larger industries, Zenrez helps studios enhance their revenue, increase customer retention, and fill last-minute class spots. The platform connects fitness enthusiasts with curated local boutique studios, allowing users to discover and book high-quality classes without the need for monthly memberships or fees. Additionally, Zenrez's CRM platform identifies key growth factors and actionable fitness-specific performance indicators, empowering studios to optimize their acquisition and retention strategies.

Fabric Genomics (formerly Omicia)

Series B in 2016
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Solazyme

Post in 2016
Solazyme is a synthetic biology company that specializes in converting algal biomass into biofuels. Solazyme not only creates biofuels for the the transportation industry, but is experimenting with ways to tailor its products for the cosmetic and food industries.

Zenrez

Seed Round in 2015
Zenrez Corporation, founded in 2014 and based in San Francisco, California, operates a mobile application that facilitates the booking of gyms and fitness centers. The company provides boutique fitness studios with advanced sales and marketing software focused on revenue management. By employing dynamic pricing and yield management techniques typically used in larger industries, Zenrez helps studios enhance their revenue, increase customer retention, and fill last-minute class spots. The platform connects fitness enthusiasts with curated local boutique studios, allowing users to discover and book high-quality classes without the need for monthly memberships or fees. Additionally, Zenrez's CRM platform identifies key growth factors and actionable fitness-specific performance indicators, empowering studios to optimize their acquisition and retention strategies.

Bracket Computing

Series C in 2015
Bracket Computing Inc. specializes in workload isolation software that enables enterprises to securely manage workloads in hybrid cloud environments. Founded in 2011 and based in Mountain View, California, the company provides advanced IT security measures, including crypto-enforced micro-segmentation, which ensures continuous encryption of data both at rest and in motion, utilizing customer-controlled keys. Its platform also features data and runtime integrity monitoring, along with auditability and forensics capabilities that capture critical information at the time of a security breach. By consolidating security controls, Bracket Computing aims to protect enterprises from malware, insider threats, and human errors, all while maintaining the agility and speed of self-service cloud operations.

Stemcentrx

Series G in 2015
Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and significantly enhancing patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in disease-specific treatments that target tumors at their source, specifically by eliminating cancer stem cells, which are responsible for initiating and sustaining tumor growth. This approach helps healthcare providers offer more effective solutions to their patients. In June 2016, Stemcentrx became a subsidiary of AbbVie, furthering its capabilities in cancer research and drug development.

Cohesity

Series B in 2015
Cohesity, Inc. is a data management technology company that specializes in hyper-converged secondary storage solutions for large organizations. Founded in 2013 and based in Santa Clara, California, with an additional office in Raleigh, North Carolina, Cohesity aims to simplify the protection, management, and extraction of value from data. Its flagship product, the Cohesity DataPlatform, consolidates secondary data and workflows, eliminating storage silos and streamlining data management. The company also offers DataProtect, which integrates various data protection functions, including backup and disaster recovery, as well as the Cohesity Orion platform for comprehensive data protection and big data storage. Additionally, Cohesity provides tools for monitoring and managing data infrastructure through its SaaS-based solution, Cohesity Helios, and its mobile application. The company serves clients across the Americas, EMEA, and APAC, and maintains a strategic partnership with Pure Storage to enhance its offerings.

Stringify

Seed Round in 2015
Stringify is a technology company focused on creating a platform that connects both physical and digital elements seamlessly. By leveraging automation services for the Internet of Things, Stringify enables users to discover, design, and control their experiences by linking the aspects of their lives that matter most. The platform provides customers with convenient access to their connected devices without the need for additional hardware, allowing for a hassle-free experience. Through its innovative solutions, Stringify aims to enhance daily living by simplifying the connectivity of diverse technologies.

Quid

Series D in 2015
Quid, Inc. develops a platform that searches, analyzes, and visualizes collective intelligence to address strategic inquiries. Its software specializes in analyzing text-based data, utilizing advanced techniques such as implicit network analysis and graph theory to create interactive visualizations. Through proprietary algorithms that incorporate artificial intelligence and natural language processing, Quid efficiently uncovers insights from extensive datasets, including news articles, blog posts, company profiles, and patents. The platform is designed for non-technical users in enterprise organizations, enabling them to independently access valuable information and generate unique insights. Quid caters to various sectors, including marketing, public relations, consulting, technology, healthcare, and financial services. Founded in 2006 and headquartered in San Francisco, California, with additional offices in New York and London, Quid merged with NetBase Solutions in January 2020, forming a combined entity known as NetBase Quid.

ChefsFeed

Series A in 2015
ChefsFeed is a food media and technology platform that connects users with the culinary industry, offering dining and drinking inspiration, guides, and unique experiences from experts. The platform features an application that utilizes users' current locations to help them discover specific dishes, while also enabling culinary professionals to share recipes and restaurant reviews. By providing insights from experts, ChefsFeed helps diners make informed choices about what to eat. The company fosters collaboration between culinary professionals and leading brands, promoting innovative partnerships both online and in-person.

Kanjoya

Venture Round in 2015
Kanjoya, Inc. operates a workforce intelligence and management platform designed for enterprise companies. The company specializes in employee engagement solutions that allow organizations to capture feedback, analyze results in real-time, and distribute vital intelligence. Its key offerings include Kanjoya Perception, which assesses employee emotions, attitudes, and intentions while predicting behaviors; a Workday directory that facilitates employee surveys and performance reviews; and Perception for Performance, a tool that helps managers evaluate, reward, and motivate employees. By leveraging advanced artificial intelligence, natural language processing, and machine learning, Kanjoya provides insights into the motivations and emotions driving business outcomes. Founded in 2006 and based in San Francisco, California, Kanjoya was previously known as Experience Project, Inc. The company has been a subsidiary of The Ultimate Software Group, Inc. since September 2016.

Versa Networks

Series B in 2014
Versa Networks, Inc. is a company specializing in software-defined networking (SDN) solutions with a focus on virtualized network functions and services. Founded in 2012 and headquartered in Santa Clara, California, with an additional office in Bengaluru, India, Versa aims to secure and simplify modern networks for enterprises and service providers. Their offerings include Secure Access Service Edge (SASE), which integrates security and advanced networking capabilities, alongside a full-featured software-defined wide area network (SD-WAN). Versa's platform supports multitenancy and sophisticated analytics, allowing deployment across cloud, on-premises, or hybrid environments. This versatility helps organizations reduce costs associated with wide area networks and branch infrastructure. Thousands of customers globally rely on Versa to manage their networking and security needs.

Palantir Technologies

Series I in 2014
Palantir Technologies, established in 2003, specializes in developing data integration and analysis platforms. The company offers two primary products: Palantir Gotham, designed for enterprises to manage, secure, and analyze data, and Palantir Metropolis, focused on quantitative data analysis. Palantir serves a wide range of sectors, including government, defense, finance, healthcare, and others, helping them make sense of large, complex data sets. The company is headquartered in Palo Alto, California.

Stateless Networks

Series A in 2014
Stateless Networks Inc. is a company that specializes in performance infrastructure and networking solutions tailored for enterprises, service providers, and the federal government. Founded in 2012 and headquartered in San Francisco, California, Stateless offers the Stateless AutoWare SDN Fabric Manager, a software application designed to enhance network monitoring and management. This tool facilitates quicker deployments, boosts resilience, automates administrative tasks, and enables swift recovery from service disruptions. The company focuses on transforming network operations through a combination of deep network insights and advanced distributed systems, catering specifically to enterprise data centers. Stateless collaborates with leading network and infrastructure vendors to provide solutions to major private data center operators, emphasizing the integration of physical and virtual networking layers.

Tastemade

Series C in 2014
Tastemade, Inc. is a media company that specializes in producing and delivering content for a global community of food enthusiasts. Founded in 2012 and headquartered in Santa Monica, California, Tastemade offers a variety of themed shows, including video recipes and cooking programs, accessible through its YouTube channel and food channels across the Americas, Europe, and Asia. The company also features a mobile application for iPhone users, allowing them to discover, create, and share food-related videos. In addition, Tastemade provides online tutorials covering topics such as food photography, food styling, and video production techniques. With a focus on connecting people through food and travel, Tastemade aims to create engaging stories that resonate with audiences on digital and streaming platforms.

Modern Meadow

Series A in 2014
Modern Meadow, LLC is a biofabrication company based in Brooklyn, New York, founded in 2011. The company specializes in creating animal-free leather from living cells, utilizing its proprietary Bio-Alloy and Bio-Farm technology platforms. These innovations leverage tuned proteins to produce sustainable materials that eliminate the need for petrochemical and animal-derived inputs while maintaining high performance. Modern Meadow’s products are designed for seamless integration into existing infrastructures across various industries, including materials and beauty. The company emphasizes lab-to-brand traceability, ensuring that its offerings are fully transparent throughout the production process. By focusing on fermentation-based bio-collagen and lightweight materials, Modern Meadow aims to significantly reduce greenhouse gas emissions and promote sustainability without compromising quality or appearance.

Stateless Networks

Convertible Note in 2014
Stateless Networks Inc. is a company that specializes in performance infrastructure and networking solutions tailored for enterprises, service providers, and the federal government. Founded in 2012 and headquartered in San Francisco, California, Stateless offers the Stateless AutoWare SDN Fabric Manager, a software application designed to enhance network monitoring and management. This tool facilitates quicker deployments, boosts resilience, automates administrative tasks, and enables swift recovery from service disruptions. The company focuses on transforming network operations through a combination of deep network insights and advanced distributed systems, catering specifically to enterprise data centers. Stateless collaborates with leading network and infrastructure vendors to provide solutions to major private data center operators, emphasizing the integration of physical and virtual networking layers.

Stemcentrx

Series F in 2014
Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and significantly enhancing patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in disease-specific treatments that target tumors at their source, specifically by eliminating cancer stem cells, which are responsible for initiating and sustaining tumor growth. This approach helps healthcare providers offer more effective solutions to their patients. In June 2016, Stemcentrx became a subsidiary of AbbVie, furthering its capabilities in cancer research and drug development.

Bitnet

Convertible Note in 2014
Bitnet operates a digital commerce platform designed to enable enterprise-scale merchants to accept bitcoin payments. The company focuses on developing an online payment solution that facilitates transactions in cryptocurrency, catering specifically to larger businesses seeking to integrate bitcoin into their payment systems. Bitnet's team comprises experienced professionals from the technology and payment sectors, including key contributors to the development of CyberSource, one of the largest payment gateways, which was acquired by Visa. Through its platform, Bitnet aims to streamline the process of accepting digital currency and enhance the overall payment experience for merchants and their customers.

Fabric Genomics (formerly Omicia)

Series A in 2014
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Bracket Computing

Series B in 2014
Bracket Computing Inc. specializes in workload isolation software that enables enterprises to securely manage workloads in hybrid cloud environments. Founded in 2011 and based in Mountain View, California, the company provides advanced IT security measures, including crypto-enforced micro-segmentation, which ensures continuous encryption of data both at rest and in motion, utilizing customer-controlled keys. Its platform also features data and runtime integrity monitoring, along with auditability and forensics capabilities that capture critical information at the time of a security breach. By consolidating security controls, Bracket Computing aims to protect enterprises from malware, insider threats, and human errors, all while maintaining the agility and speed of self-service cloud operations.

Quid

Convertible Note in 2013
Quid, Inc. develops a platform that searches, analyzes, and visualizes collective intelligence to address strategic inquiries. Its software specializes in analyzing text-based data, utilizing advanced techniques such as implicit network analysis and graph theory to create interactive visualizations. Through proprietary algorithms that incorporate artificial intelligence and natural language processing, Quid efficiently uncovers insights from extensive datasets, including news articles, blog posts, company profiles, and patents. The platform is designed for non-technical users in enterprise organizations, enabling them to independently access valuable information and generate unique insights. Quid caters to various sectors, including marketing, public relations, consulting, technology, healthcare, and financial services. Founded in 2006 and headquartered in San Francisco, California, with additional offices in New York and London, Quid merged with NetBase Solutions in January 2020, forming a combined entity known as NetBase Quid.

Palantir Technologies

Series H in 2013
Palantir Technologies, established in 2003, specializes in developing data integration and analysis platforms. The company offers two primary products: Palantir Gotham, designed for enterprises to manage, secure, and analyze data, and Palantir Metropolis, focused on quantitative data analysis. Palantir serves a wide range of sectors, including government, defense, finance, healthcare, and others, helping them make sense of large, complex data sets. The company is headquartered in Palo Alto, California.

LookSharp

Series A in 2013
LookSharp (powering InternMatch) is an online platform that connects students with amazing companies and helps companies hire amazing students. LookSharp allows companies of all sizes to build their employment brand on campus and expand their college hiring reach to more universities. Founded in 2009 by Andrew Maguire and Nathan Parcells, InternMatch (now LookSharp) began as a Washington only platform. In September of 2010 InternMatch expanded their services to the west coast. In November of 2011 InternMatch expanded nationally and launched their Campus Hub product which stays up year-round and displays rich content about a company including, video, photos and social media streams. The goal is help students better select where to apply and help companies find hires more likely to succeed. In January of 2013 InternMatch expanded their Campus Hub so companies use it to not only act as a central, easy to update location for their internship programs, but also could build unique messages for underclassmen, diverse students and new grad hires. InternMatch also launched a pared down self-service version of their Campus Hub, allowing smaller students to add rich content and helping make the internship discover process for students on InternMatch more complete. Overall, to support it's college hiring ecosystem LookSharp focuses on three things: First, LookSharp is looking to make the internship search and posting process incredibly simple. On the LookSharp platform both internship seekers and employers can search for a match, receive skill and location based matching recommendations, and access tools to manage the application process. Students can also search and apply to opportunities without registering. Second, LookSharp has built and continues to construct an evolving library of resources and tools. Students can access tools for resume creation, internship preparation, and more. Organizations can access resources that help with intern management, program development and advice on compensation. Third, LookSharp has built the infrastructure to help interested students connect with socially responsible positions especially at nonprofit organizations. Rather than volunteer, students recognize the value in experiential learning that combines positive social impact with career building which is a key tenet for LookSharp.

Versa Networks

Series A in 2012
Versa Networks, Inc. is a company specializing in software-defined networking (SDN) solutions with a focus on virtualized network functions and services. Founded in 2012 and headquartered in Santa Clara, California, with an additional office in Bengaluru, India, Versa aims to secure and simplify modern networks for enterprises and service providers. Their offerings include Secure Access Service Edge (SASE), which integrates security and advanced networking capabilities, alongside a full-featured software-defined wide area network (SD-WAN). Versa's platform supports multitenancy and sophisticated analytics, allowing deployment across cloud, on-premises, or hybrid environments. This versatility helps organizations reduce costs associated with wide area networks and branch infrastructure. Thousands of customers globally rely on Versa to manage their networking and security needs.

Nimble Storage

Series E in 2012
Nimble Storage, Inc. specializes in flash storage solutions, providing a range of products that include all-flash arrays, adaptive flash arrays, and multi-cloud storage services. The company's offerings are designed to enhance performance and simplify operations for various business applications, including databases, virtual servers, and data analytics. Nimble's patented Cache Accelerated Sequential Layout (CASL) architecture combines flash with high-capacity drives, enabling high performance at an affordable cost while improving disaster recovery and backup processes. Their predictive cloud platform, InfoSight, incorporates predictive analytics to optimize storage management across on-premises data centers and cloud environments. Nimble Cloud Volumes allow customers to run applications in leading cloud services like Amazon Web Services and Microsoft Azure. The company distributes its products through a network of value-added resellers and integrators, serving diverse sectors including healthcare, finance, education, and technology. Founded in 2007 and based in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.

ClearEdge Power

Series E in 2011
ClearEdge Power specializes in onsite energy generation systems designed for residential and small commercial use. The company offers compact power and heat energy solutions that range from 5 kW to multiple megawatts, enabling customers to achieve reliable and efficient energy production. Their systems not only serve as backup power for essential appliances like refrigerators and electronics but also help users reduce electricity costs, enhance energy efficiency, and minimize carbon emissions. As a leading fuel cell producer, ClearEdge Power is committed to transforming power generation with innovative technologies that support cleaner and more sustainable energy practices.

Quid

Series C in 2011
Quid, Inc. develops a platform that searches, analyzes, and visualizes collective intelligence to address strategic inquiries. Its software specializes in analyzing text-based data, utilizing advanced techniques such as implicit network analysis and graph theory to create interactive visualizations. Through proprietary algorithms that incorporate artificial intelligence and natural language processing, Quid efficiently uncovers insights from extensive datasets, including news articles, blog posts, company profiles, and patents. The platform is designed for non-technical users in enterprise organizations, enabling them to independently access valuable information and generate unique insights. Quid caters to various sectors, including marketing, public relations, consulting, technology, healthcare, and financial services. Founded in 2006 and headquartered in San Francisco, California, with additional offices in New York and London, Quid merged with NetBase Solutions in January 2020, forming a combined entity known as NetBase Quid.

Nimble Storage

Series D in 2011
Nimble Storage, Inc. specializes in flash storage solutions, providing a range of products that include all-flash arrays, adaptive flash arrays, and multi-cloud storage services. The company's offerings are designed to enhance performance and simplify operations for various business applications, including databases, virtual servers, and data analytics. Nimble's patented Cache Accelerated Sequential Layout (CASL) architecture combines flash with high-capacity drives, enabling high performance at an affordable cost while improving disaster recovery and backup processes. Their predictive cloud platform, InfoSight, incorporates predictive analytics to optimize storage management across on-premises data centers and cloud environments. Nimble Cloud Volumes allow customers to run applications in leading cloud services like Amazon Web Services and Microsoft Azure. The company distributes its products through a network of value-added resellers and integrators, serving diverse sectors including healthcare, finance, education, and technology. Founded in 2007 and based in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.

Practice Fusion

Series B in 2011
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California, founded in 2005. The company specializes in providing a comprehensive practice management software platform that facilitates various healthcare functions, including charting, scheduling, billing, e-prescribing, lab integrations, and secure messaging. By connecting doctors, patients, and data, Practice Fusion aims to enhance healthcare delivery and improve patient outcomes. Its platform serves a diverse range of users, including independent medical practices, large medical groups, and community clinics, as well as life science partners. Additionally, Practice Fusion Insight offers a healthcare database to support medical professionals in their practice. As of February 2018, Practice Fusion operates as a subsidiary of Allscripts Healthcare Solutions, Inc.

Stemcentrx

Series C in 2011
Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and significantly enhancing patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in disease-specific treatments that target tumors at their source, specifically by eliminating cancer stem cells, which are responsible for initiating and sustaining tumor growth. This approach helps healthcare providers offer more effective solutions to their patients. In June 2016, Stemcentrx became a subsidiary of AbbVie, furthering its capabilities in cancer research and drug development.

Tilera

Series D in 2011
Tilera Corporation is a fabless semiconductor company that specializes in designing multicore embedded processors tailored for the networking, digital multimedia, and wireless infrastructure sectors. Founded in 2004 and headquartered in San Jose, California, with additional locations in Westborough, Massachusetts, and Beijing, China, Tilera offers a range of products including the TILEPro multicore processor, which provides high-performance computing for various embedded applications. The company also develops multicore software development tools and production boards, such as TILExpress PCIe cards, to support its processors. Tilera's innovations aim to meet the processing and power needs of modern digital and wireless infrastructures.

Oorja Fuel Cells

Debt Financing in 2010
Oorja Fuel Cells is a global energy company focused on advancing the methanol economy through the design, development, and commercialization of Direct Methanol Fuel Cells (DMFCs). These fuel cells, which range in power from 0.5 to 100 kilowatts, serve various industries including telecommunications, transportation, distributed energy, and microgrids. Founded in 2004 in Silicon Valley, Oorja Fuel Cells aims to provide high-power solutions that significantly lower operating costs and reduce greenhouse gas emissions. By utilizing a combination of methanol fuel and traditional battery technology, the company enables original equipment manufacturers and other sectors to decrease harmful emissions effectively. Oorja Fuel Cells is backed by prominent global investors, underscoring its potential impact in the energy market.

VUDU

Series C in 2008
Vudu, Inc. is a provider of digital entertainment services that allows consumers to access a wide range of movies and television shows through its online platform. The company offers products such as the Vudu Box and Vudu XL, which enable streaming on various devices including HDTVs, Blu-ray players, and gaming consoles. Vudu's service is designed to provide users with content without the need for subscriptions or contracts, thus enhancing accessibility. In addition to its streaming services, Vudu sells accessories like replacement remotes and power supplies. The company collaborates with movie studios, independent filmmakers, and distributors to curate its extensive library of content. Vudu, Inc. was previously known as Marquee, Inc.

Dash Navigation

Series C in 2008
Dash Navigation has plans to change your automotive GPS units for good by bringing maps mashups as well as internet capability. Unlike today's car GPS units which necessitate extra downloads to update map changes, add features or otherwise, Dash Navigation updates and extra features will all come via web connection in real time. The device will be connected through a cellular data network and will also sport WiFi connectivity. The device will collect data about traffic conditions from all other Dash drivers, and estimates how long alternative routes will take on any given day. All sorts of geo-tagged information can be pushed to the device and combined with the on-board maps. Everything from restaurants and open houses to concerts, gas, and golf courses could be sent to the Dash and appear there on your screen. Owners will be able to manage which mashups they receive through Dash's Website. There, they will be able to drag feeds from sites like [Platial](http://crunchbase.com/organization/platial), where they can create a Google Map of dog runs in San Francisco or yoga schools in LA. Link it to [Zillow](http://crunchbase.com/organization/zillow), and you will be able to get data on houses as you are driving around the neighborhood. Create a feed at Upcoming.org about all the rock concerts in your city or one of open houses from Craigslist, and you will be able to get the info in your car, along with how far away each place is. You will also be able to do a Yahoo Local search on the device for restaurants and it will return nearby results with ratings. The company is backed by both VC powerhouses, Sequoia Capital and Kleiner Perkins as well as a slew of others.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.